164
Participants
Start Date
December 25, 2021
Primary Completion Date
November 21, 2022
Study Completion Date
December 14, 2022
Olanzapine 5 MG
, Olanzapine (OLZ) is an atypical antipsychotic agent that blocks multiple neurotransmitters: dopamine at D1, D2, D3 and D4 brain receptors, serotonin at 5-HT2a , 5-HT2c, 5-HT3, and 5-HT6receptors, catecholamines at alpha 1 adrenergic receptors, acetylcholine at muscarinic receptors, and histamine at H1 receptors is suggested to have a valuable role in CAC
Placebo
Tablets containing 300 mg of microcrystalline cellulose. It will be identical to the active drug
Kasr Al-Ainy Center of Clinical Oncology & Nuclear Medicine, Cairo
Cairo University
OTHER